About Advaccine

Advaccine is an innovative vaccine company with a high-value prophylactic and therapeutic vaccine pipeline driven by in-house developed technology platforms.

To date, our pipeline consists of potential first-in-class key assets developed to address diseases caused by SARS-CoV-2, respiratory syncytial virus (RSV) and hepatitis B virus (HBV), which are diseases with huge unmet medical needs. We are also developing vaccine candidates in preclinical stage covering viral-related oncology, as well as neoantigen therapeutic vaccines and tumor-associated antigen therapeutic vaccines.